Temasek leads $59 million Series B in biotech firm Just China

Temasek leads $59 million Series B in biotech firm Just China

Medicine, biotechnology, DNA, genetics and healthcare. Image: Pixabay

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter